Few Eyebrows Up

Nov 02, 2018

Some experts have raised concerned about 23andMe's new direct-to-consumer pharmacogenetic tests, Time reports.

The US Food and Drug Administration earlier this week gave 23andMe authorization to sell tests for 33 variants linked to the ability to break down certain drugs, as GenomeWeb has reported.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Halt Under Consideration

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

How's It Going to Go Over?

The Associated Press reports that gene-edited food may soon be for sale.

Meetings on Fetal Research

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

This Week in Cell

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.

Main menu

Few Eyebrows Up

To read the full story....

The Scan

Halt Under Consideration

How's It Going to Go Over?

Meetings on Fetal Research

This Week in Cell

What's Popular?

Trace Genomics Raises $13M in Series A Financing Round

Point-of-Care Molecular Diagnostic Platform That Skips Need for Amplification Being Developed at UCLA

Bio-Rad Awarded $24M in 10x Genomics Patent Infringement Lawsuit

Illumina's Proposed PacBio Acquisition Leaves Customers Cautiously Optimistic

CareDx Prices $49M Common Stock Offering

Sponsorships